Literature DB >> 20059396

Four new HIV-1 group N isolates from Cameroon: Prevalence continues to be low.

Ana Vallari1, Pierre Bodelle, Charlotte Ngansop, Florence Makamche, Nicaise Ndembi, Dora Mbanya, Lazare Kaptué, Lutz G Gürtler, Carole P McArthur, Sushil G Devare, Catherine A Brennan.   

Abstract

Analysis of 3555 HIV-seropositive specimens, collected in Cameroon from 2002 to 2006, led to the identification of four HIV-1 group N infections based on differential seroreactivity to HIV env-derived peptides and proteins and confirmation by nucleic acid amplification. Group N prevalence continues to be low accounting for only 0.1% of HIV infections in Cameroon. Near full-length genomic sequences were obtained from viral RNA or proviral DNA by PCR amplification of overlapping fragments for three isolates, 06CM-U14296, 06CM-U14842, and 02CM-SJGddd. Two genome segments, partial pol and env-nef, were obtained from viral RNA for the fourth isolate, 02CM-TIM0217. With the four group N isolates identified in this study and group N sequences previously reported, eight near full-length and five partial genome sequences are now available. Despite genetic divergence from HIV-1 group M and O, all of the group N infections evaluated by five commercial HIV immunoassays were detected.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20059396     DOI: 10.1089/aid.2009.0178

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  18 in total

1.  Characterization of HIV type 1 envelope sequence among viral isolates circulating in the northern region of Colombia, South America.

Authors:  José-Luis Villarreal; Jaime Gutiérrez; Lucy Palacio; Martha Peñuela; Robin Hernández; Guy Lemay; Guillermo Cervantes-Acosta
Journal:  AIDS Res Hum Retroviruses       Date:  2012-05-21       Impact factor: 2.205

2.  Molecular epidemiology of HIV type 1 CRF02_AG in Cameroon and African patients living in Italy.

Authors:  Nazle Mendonca Collaço Véras; Maria Mercedes Santoro; Rebecca R Gray; Andrew J Tatem; Alessandra Lo Presti; Flaminia Olearo; Giulia Cappelli; Vittorio Colizzi; Desiré Takou; Judith Torimiro; Gianluca Russo; Annapaola Callegaro; Romina Salpini; Roberta D'Arrigo; Carlo-Federico Perno; Maureen M Goodenow; Massimo Ciccozzi; Marco Salemi
Journal:  AIDS Res Hum Retroviruses       Date:  2011-05-06       Impact factor: 2.205

3.  Autocatalytic maturation, physical/chemical properties, and crystal structure of group N HIV-1 protease: relevance to drug resistance.

Authors:  Jane M Sayer; Johnson Agniswamy; Irene T Weber; John M Louis
Journal:  Protein Sci       Date:  2010-11       Impact factor: 6.725

4.  Efficient SIVcpz replication in human lymphoid tissue requires viral matrix protein adaptation.

Authors:  Frederic Bibollet-Ruche; Anke Heigele; Brandon F Keele; Juliet L Easlick; Julie M Decker; Jun Takehisa; Gerald Learn; Paul M Sharp; Beatrice H Hahn; Frank Kirchhoff
Journal:  J Clin Invest       Date:  2012-04-16       Impact factor: 14.808

Review 5.  Non-M variants of human immunodeficiency virus type 1.

Authors:  Thomas Mourez; François Simon; Jean-Christophe Plantier
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

6.  Confirmation of putative HIV-1 group P in Cameroon.

Authors:  Ana Vallari; Vera Holzmayer; Barbara Harris; Julie Yamaguchi; Charlotte Ngansop; Florence Makamche; Dora Mbanya; Lazare Kaptué; Nicaise Ndembi; Lutz Gürtler; Sushil Devare; Catherine A Brennan
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

Review 7.  Origins of HIV and the AIDS pandemic.

Authors:  Paul M Sharp; Beatrice H Hahn
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

8.  Experimental Adaptive Evolution of Simian Immunodeficiency Virus SIVcpz to Pandemic Human Immunodeficiency Virus Type 1 by Using a Humanized Mouse Model.

Authors:  Kei Sato; Naoko Misawa; Junko S Takeuchi; Tomoko Kobayashi; Taisuke Izumi; Hirofumi Aso; Shumpei Nagaoka; Keisuke Yamamoto; Izumi Kimura; Yoriyuki Konno; Yusuke Nakano; Yoshio Koyanagi
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

Review 9.  Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia.

Authors:  Georgios K Nikolopoulos; Evangelia-Georgia Kostaki; Dimitrios Paraskevis
Journal:  Infect Genet Evol       Date:  2016-06-07       Impact factor: 3.342

10.  Enhanced nicotine metabolism in HIV-1-positive smokers compared with HIV-negative smokers: simultaneous determination of nicotine and its four metabolites in their plasma using a simple and sensitive electrospray ionization liquid chromatography-tandem mass spectrometry technique.

Authors:  Ravinder Earla; Anusha Ande; Carole McArthur; Anil Kumar; Santosh Kumar
Journal:  Drug Metab Dispos       Date:  2013-12-03       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.